← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Eva Nilsagård
Styrelseledamot
Profile key: se|eva nilsagård
Purchase history
- Companies traded
- 4
- Purchases · 12M
- 3
- Purchases · 24M
- 5
- Average purchase
- SEK 322,557
- Gross purchase value
- SEK 1,612,785
- Last purchase
- 2026-07-27
- Completed 20D events
- 5.0
- Outcome status
- PASS
Latest company: Apotea AB (Publ)
Companies: AddLife AB | Apotea AB (Publ) | Bufab AB (publ) | Nimbus Group AB (publ)
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 5Developing | 100.0% (5/5) | 40.0% (2/5) | -0.6% | -0.1% | -4.5% |
| 20D | 5Developing | 100.0% (5/5) | 40.0% (2/5) | -0.8% | +0.6% | -3.0% |
| 60D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +5.7% | +5.0% | -2.7% |
| 120D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +12.7% | +9.9% | -0.1% |
Research patterns
- First purchase in 12M
- 3/3
- Large purchase ≥ €100k
- 0/5
- Cluster buying · 15D
- 3/5
- Buying the dip · ≥20% below prior 52W high
- 3/5
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.